LPCN

Lipocine Inc.

8.65

USD

LPCN Earnings Reports

Positive Surprise Ratio

LPCN beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report

Mar 11, 2026

Estimate for Q4 25 (Revenue/ EPS)

$118.32K

-$0.62

Implied change from Q3 25 (Revenue/ EPS)

+2.89%

+5.08%

Implied change from Q4 24 (Revenue/ EPS)

-96.61%

-133.33%

Lipocine Inc. earnings per share and revenue

On Nov 06, 2025, LPCN reported earnings of -0.59 USD per share (EPS) for Q3 25, missing the estimate of -0.55 USD, resulting in a -7.12% surprise. Revenue reached 115.00 thousand, compared to an expected 242.76 thousand, with a -52.63% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 118.32 thousand USD, implying an increase of 5.08% EPS, and increase of 2.89% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Lipocine Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Lipocine Inc. reported EPS of -$0.59, missing estimates by -7.12%, and revenue of $115.00K, -52.63% below expectations.

How did the market react to Lipocine Inc.'s Q3 2025 earnings?

The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.

When is Lipocine Inc. expected to report next?

The next earning report is scheduled for Mar 11, 2026.

What are the forecasts for Lipocine Inc.'s next earnings report?

Based on 4 analysts, Lipocine Inc. is expected to report EPS of -$0.62 and revenue of $118.32K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.